Table 3. Hematopoietic Chimerism of... | American Society of Hematology

Table 3.

Hematopoietic Chimerism of Recipient F1 Mice After Parental BM Grafting

Recipient	Treatment^3-150	Donor	BM Cells^3-151	Hematopoietic Chimerism^3-152
				H-2^b/b	H-2^b/d
B6D2F1	None	B6	1 × 10⁵	6.2%	91.0%
				8.5%	90.4%
				16.5%	82.4%
B6D2F1	G-CSF	B6	1 × 10⁵	42.0%	55.0%
				54.0%	40.3%
				60.2%	38.2%

Recipient	Treatment^3-150	Donor	BM Cells^3-151	Hematopoietic Chimerism^3-152
				H-2^b/b	H-2^b/d
B6D2F1	None	B6	1 × 10⁵	6.2%	91.0%
				8.5%	90.4%
				16.5%	82.4%
B6D2F1	G-CSF	B6	1 × 10⁵	42.0%	55.0%
				54.0%	40.3%
				60.2%	38.2%

G-CSF at 25 μg/kg/d was administered subcutaneously with a miniosmotic pump starting on day −14 and BM cells were grafted on day 0.

Number of T-cell–depleted B6 BM cells transplanted.

Hematopoietic chimerism was examined on day 40. Cells with H-2^b/b and H-2^b/d phenotypes correspond to donor and recipient, respectively.